Englewood Lab Inc

Englewood Lab Inc maintains a strong liquidity position, with a current ratio of 3.55 and cash and equivalents amounting to $25,129,940. The company's liquidity is further supported by a low debt-to-equity ratio of 0.16, indicating a conservative capital structure.

In terms of profitability, the company demonstrates a return on equity of 15.21% and a return on assets of 11.03%. These figures suggest that the company is effectively utilizing its equity and assets to generate returns, outperforming the typical benchmarks for the personal products industry.

The company's revenue is concentrated in a single business segment, as disclosed in its financial statements. There is no significant geographic diversification reported, which could pose a concentration risk if the primary market experiences economic downturns.

Looking at the growth trajectory, the company's recent financial performance shows a revenue of $152,431,010. While the company has a positive operating cash flow of $15,606,710, the capital expenditure of -$4,698,180 indicates a reduction in investment in physical assets, which may affect long-term growth.

The risk assessment for Englewood Lab Inc indicates a low liquidity risk and a low dilution risk. The company has no immediate filing-based liquidity or dilution flags, and the dilution potential is minimal given the equal number of basic and diluted shares outstanding.

Recent events, as reflected in the financial data, show a strong performance in terms of net income of $17,447,730 and a gross profit of $42,204,860. The company's financial health is further supported by a high return on equity and a strong operating income of $26,274,560.